Jean-Luc Vanderheyden, PHD

Executive Director Oncidium Foundation USA

Seminars

Thursday 25th February 2027
Keeping the Patient in Mind: Building Preclinical Evidence That Better Supports Translation into Humans
9:00 am
  • Work backwards from the intended patient population and clinical setting to determine which preclinical questions need to be answered before progressing an RLT towards human studies
  • Interrogate where preclinical models accurately reflect human disease and where they fall short, using complementary evidence to strengthen confidence in translation
  • Apply lessons from previous RLT development to generate preclinical evidence that better informs clinical study design, treatment delivery and the successful progression of next-generation candidates into patients
Jean-Luc Vanderheyden, PHD, Speaker at 3rd TRP Target Selection & Drug Design Summit